EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular epidemiology and emerging tet (X)-associated resistance of Elizabethkingia spp. in Taiwan, 2016–2022

Yu-Tsung Huang, Cheng-Yen Kao iD, Han-Yueh Kuo, Li-Ting Kao, Yu-Chi Chang, Yen-Ting Liao, Li-Cheng Wu, Tzu-Ling Chen, Yu-Kai Tu, Tsung-Ying Yang iD

Antimicrobial Agents and Chemotherapy · 01.07.2026 · 70 (7)

DOI: 10.1128/aac.00387-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 01.07.2026. Verfasst von Yu-Tsung Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Flavobacteriaceae, Flavobacteriaceae Infections. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, MacKay Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Elizabethkingia species are opportunistic gram-negative pathogens associated with nosocomial infections and limited therapeutic options. Longitudinal data characterizing antimicrobial resistance and molecular determinants in Taiwan remain scarce. A total of 191 non-duplicate Elizabethkingia clinical isolates were collected at the National Taiwan University Hospital between 2016 and 2022. Species identification was confirmed by 16S rRNA sequencing. Elizabethkingia anophelis predominated (81.7%), followed by E. meningoseptica (9.9%) and E. miricola (7.9%). No major clone was identified. Genes involved in sialic acid metabolism were detected as follows: glmS in 93.2% (178/191), glmM in 97.4% (186/191), nagB in 98.4% (188/191), neuC2 in 24.5% (46/191), and neuC in 2.1% (4/191) of isolates. Antimicrobial susceptibility testing showed very high nonsusceptibility for most agents (≥99.5%). Lower rates of nonsusceptibility were observed for levofloxacin (MIC 50 /MIC 90 = 1/>8 µg/mL; 68.6% susceptible), ciprofloxacin (2/>4 µg/mL; 49.2%), tigecycline (4/>8 µg/mL; 23.0%), and rifampin (>8/>16 µg/mL; 19.9%). Using the breakpoint for other non-Enterobacterales, minocycline was active against all isolates (100.0%, 191/191); however, applying the S. maltophilia criteria, 42 isolates (22.0%) were nonsusceptible to minocycline. Among tetracycline determinants, tet (X) was detected in 22 isolates (11.5%) and tet (K) in 2 isolates (1.0%). With the criteria of S. maltophilia , 10 tet (X)-positive isolates (10/22, 45.5%) showed non-susceptibility to minocycline, implying that tet (X) may contribute to the elevated MIC of minocycline. Our surveillance revealed a rapid increase in resistance to fluoroquinolones and rifampin and the emergence of tet (X)-mediated tetracycline resistance in Elizabethkingia spp. These findings underscore the need for continued molecular monitoring and region-specific antimicrobial stewardship.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsFlavobacteriaceaeFlavobacteriaceae InfectionsTaiwanMicrobial Sensitivity TestsRNA, Ribosomal, 16SHumansMolecular EpidemiologyDrug Resistance, Multiple, Bacterial

Stichwörter der Autor:innen

Elizabethkingiaantimicrobial resistancefluoroquinolone resistancetet(X)tetracycline resistance

Substanzen

Anti-Bacterial AgentsRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Institute of Microbiology and Immunology, College of Life Science, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Division of Infectious Disease, National Taiwan University Hospital Hsin-Chu Branch, Hsin-chu, Taiwan.
  • Department of Internal Medicine, National Taiwan University Hospital Hsin-Chu Branch, Hsin-chu, Taiwan.
  • Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Department of Medical Laboratory and Regenerative Medicine, MacKay Medical University, New Taipei City, Taiwan.

ORCID-Profile: Cheng-Yen Kao, Tsung-Ying Yang

Förderung

  • National Science and Technology Council
  • MacKay Medical University

Zitieren

APA

Huang, Y. T., Kao, C. Y., Kuo, H. Y., Kao, L. T., Chang, Y. C., Liao, Y. T., Wu, L. C., Chen, T. L., Tu, Y. K., & Yang, T. Y. (2026). Molecular epidemiology and emerging tet (X)-associated resistance of Elizabethkingia spp. in Taiwan, 2016–2022. Antimicrobial Agents and Chemotherapy, 70(7). https://doi.org/10.1128/aac.00387-26

Vancouver

Huang YT, Kao CY, Kuo HY, Kao LT, Chang YC, Liao YT, et al. Molecular epidemiology and emerging tet (X)-associated resistance of Elizabethkingia spp. in Taiwan, 2016–2022. Antimicrobial Agents and Chemotherapy. 2026;70(7). doi:10.1128/aac.00387-26

BibTeX
@article{Huang2026,
  author = {Huang, Yu-Tsung and Kao, Cheng-Yen and Kuo, Han-Yueh and Kao, Li-Ting and Chang, Yu-Chi and Liao, Yen-Ting and Wu, Li-Cheng and Chen, Tzu-Ling and Tu, Yu-Kai and Yang, Tsung-Ying},
  title = {Molecular epidemiology and emerging tet (X)-associated resistance of Elizabethkingia spp. in Taiwan, 2016–2022},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  volume = {70},
  number = {7},
  doi = {10.1128/aac.00387-26}
}
Kostenlos starten →